The results of immune function demonstrated that inflammation-promoting, T cell co-inhibition, checkpoint, APC co-stimulation, T cell co-stimulation, CCR, APC co-inhibition and MHC class I responses were significantly increased in the high-risk group, which may increase the risk of death in patients with BC (Fig. 8A). The gene discussed is APC; the disease is breast cancer.